Irinotecan Liposome in Combination With Capecitabine

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 28, 2024

Primary Completion Date

September 1, 2027

Study Completion Date

December 31, 2027

Conditions
Pancreatic Cancer
Interventions
DRUG

Irinotecan liposome Capecitabine

"Irinotecan liposome: intravenous infusion, day 1, every 2 weeks Capecitabine: oral, twice daily (bid), days 1 to 7, take for one week and then have a one-week interval.~Each 2-week period is considered a treatment cycle, with an expected treatment of 6 cycles. Subsequent maintenance treatment will be determined by the investigator's protocol until disease progression or intolerable toxicity occurs."

Trial Locations (1)

518100

RECRUITING

Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center, Shenzhen

All Listed Sponsors
lead

Junjie Hang

OTHER